Iatrogenic Fever: What It Is, Why It Happens, and How to Manage It

What is Iatrogenic Fever?

Iatrogenic fever is a rise in body temperature that results from medical treatment rather than from an infection or the body’s natural response to disease. The term “iatrogenic” comes from the Greek words *iatros* (physician) and *genēs* (born of), so an iatrogenic condition is one that is caused by healthcare interventions—medications, procedures, or devices.

In most cases the fever is non‑infectious and resolves once the offending agent is removed or the underlying reaction subsides. However, because fever can also signal a serious infection, clinicians must first rule out other causes before labeling a temperature rise as iatrogenic.

Sources: Mayo Clinic; CDC; WHO (2022).^[1][2][3]

Common Causes

Below are the most frequently reported iatrogenic triggers. In many patients more than one factor contributes to the fever.

• Drug‑induced fever – antibiotics (β‑lactams, sulfonamides), antiepileptics, allopurinol, and certain antihistamines.
• Blood product transfusion reactions – febrile non‑hemolytic transfusion reactions (FNHTR) and cytokine release from stored blood.
• Intravenous immunoglobulin (IVIG) therapy – especially at high infusion rates.
• Vaccinations – live‑attenuated and some subunit vaccines can cause a transient low‑grade fever.
• Surgery and anesthesia – inflammatory response to tissue trauma, post‑operative infection‑like fever, or reactions to anesthetic agents.
• Serum or biologic therapy – monoclonal antibodies (e.g., rituximab, infliximab) and cytokine therapies.
• Radiologic contrast media – iodinated or gadolinium agents may provoke hypersensitivity fever.
• Central nervous system (CNS) procedures – lumbar puncture, ventriculostomy, or neurosurgery can cause fever via neurogenic mechanisms.
• Therapeutic hypothermia re‑warming – rebound fever after controlled cooling.
• Metabolic disturbances induced by treatment – thyroid hormone excess, adrenal insufficiency caused by abrupt steroid withdrawal, or hyperglycemia from insulin therapy.

Associated Symptoms

Because iatrogenic fever is a systemic response, patients often experience additional signs that help clinicians differentiate it from infectious fever:

• Chills or rigors (often less severe than with bacterial sepsis)
• Headache or mild neck stiffness (especially after meningitis‑type procedures)
• Rash or urticaria when the cause is a drug allergy
• Joint or muscular aches (myalgias) that may mimic flu‑like illness
• Flushing or feeling “warm” without sweating
• Elevated inflammatory markers (ESR, CRP) that may be modestly raised
• In transfusion‑related cases: itching, hives, or mild hypotension

When to See a Doctor

Most iatrogenic fevers are low‑grade (≤38.3 °C / 101 °F) and self‑limited. However, you should seek medical attention promptly if you notice any of the following:

• A temperature > 38.9 °C (101.9 °F) that persists more than 24 hours.
• Rapidly rising fever or a “spiking” pattern.
• New or worsening shortness of breath, chest pain, or palpitations.
• Severe headache, neck stiffness, or altered mental status.
• Widespread rash, hives, swelling of the face or throat (possible anaphylaxis).
• Persistent vomiting, severe abdominal pain, or diarrhea.
• Any sign of infection at a surgical site (redness, drainage, foul odor).

Diagnosis

Diagnosing iatrogenic fever is largely a process of exclusion and correlation with recent medical interventions.

History & Physical Examination

• Detailed medication list (prescriptions, over‑the‑counter, supplements) and timing of each dose.
• Recent procedures, surgeries, transfusions, or contrast studies.
• Onset of fever relative to the intervention (most drug fevers appear 7–10 days after exposure, transfusion fevers within 1–2 hours).
• Full physical exam to look for focal signs of infection.

Laboratory & Imaging Studies

• Complete blood count (CBC) – may show leukocytosis but often normal.
• Inflammatory markers: C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR); mild elevation is typical.
• Blood cultures – ordered when infection cannot be ruled out.
• Urinalysis, chest X‑ray, or other imaging based on clinical suspicion.
• Specific tests: drug‑dependent lymphocyte transformation test (rarely used), serum tryptase for anaphylaxis, or cytokine panels for biologic‑therapy reactions.

Diagnostic Criteria (Simplified)

1. Fever ≥ 38 °C (100.4 °F) on at least two occasions.
2. Temporal relationship with a known iatrogenic trigger.
3. Absence of an alternative infectious or inflammatory source after appropriate work‑up.
4. Resolution of fever after withdrawal or modification of the offending agent.

Treatment Options

Management focuses on removing the trigger, supportive care, and, when needed, pharmacologic therapy.

1. Discontinue or Replace the Offending Agent

• For drug‑induced fever, stop the suspect medication and substitute an alternative if therapy is essential (e.g., switch from a β‑lactam to a macrolide).
• In transfusion reactions, stop the transfusion immediately and treat with antipyretics.
• If a biologic agent is responsible, hold the next dose and discuss desensitization or replacement.

2. Antipyretics

• Acetaminophen 500–1000 mg every 6 hours (max 3 g/day) is first‑line for most patients.
• Ibuprofen 200–400 mg every 6–8 hours can be used if no contraindications (e.g., renal disease, gastric ulcer).
• Avoid NSAIDs if the fever is related to platelet‑inhibiting agents or bleeding risk.

3. Supportive Measures

• Maintain adequate hydration—oral fluids or IV crystalloids if oral intake is poor.
• Cooling measures: lukewarm sponge bath, cooling blankets, or fan‑assisted airflow.
• Rest and a balanced diet to support immune recovery.

4. Specific Therapies

• For transfusion reactions: antipyretics plus antihistamines (e.g., diphenhydramine 25‑50 mg).
• For IVIG‑related fever: pre‑medication with acetaminophen and a low dose of steroids (e.g., methylprednisolone 1 mg/kg) can blunt the reaction.
• For biologic‑induced cytokine release syndrome: short‑course steroids (e.g., prednisone 0.5 mg/kg) or tocilizumab in severe cases.

5. Follow‑up

Patients should be re‑evaluated within 48–72 hours after the offending agent is stopped. If the fever persists, a repeat work‑up for infection is warranted.

Prevention Tips

• Medication review: Keep an up‑to‑date list of all drugs and share it with every prescriber. Ask about known fever‑inducing side effects.
• Allergy documentation: Record any previous drug reactions in your medical record and carry an allergy card.
• Transfusion safety: Ensure blood is properly matched and warmed; pre‑medicate high‑risk patients with antipyretics.
• Vaccination timing: Schedule routine vaccines when you can monitor for a low‑grade fever (typically within 48 hours) and stay hydrated.
• Infusion practices: Follow recommended infusion rates for IVIG, biologics, and contrast media; ask nurses to monitor temperature during and after the infusion.
• Post‑operative care: Follow wound‑care instructions, encourage early ambulation, and report any new fever promptly.
• Patient education: Know the typical onset window for fever after a given procedure or medication—this empowers you to differentiate normal from concerning patterns.

Emergency Warning Signs

If you notice any of the following, seek immediate medical attention (call 911 or go to the nearest emergency department):

• Fever ≥ 40 °C (104 °F) or a rapid rise (> 2 °C/3.6 °F in an hour).
• Severe shortness of breath, chest pain, or sudden drop in blood pressure.
• Severe, generalized rash with swelling of the face, lips, or tongue (possible anaphylaxis).
• New onset confusion, seizures, or loss of consciousness.
• Persistent vomiting or diarrhea leading to dehydration.
• Signs of a serious infection at a surgical site: pus, foul odor, spreading redness.

© 2026 HealthLine Content. Sources: Mayo Clinic, CDC, NIH, WHO, Cleveland Clinic.